Package 61703-161-05

Brand: methotrexate

Generic: methotrexate
NDC Package

Package Facts

Identity

Package NDC 61703-161-05
Digits Only 6170316105
Product NDC 61703-161
Product ID 61703-161_6bb8643f-6ab4-4e1c-bcf9-b82e8cf18910
Description

5 VIAL, MULTI-DOSE in 1 CARTON (61703-161-05) / 2 mL in 1 VIAL, MULTI-DOSE (61703-161-02)

Marketing

Marketing Status
Marketed Since 2024-11-04
Brand methotrexate
Generic methotrexate
Sample Package No

Linked Drug Pages (1)

Methotrexate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRATHECAL", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "6bb8643f-6ab4-4e1c-bcf9-b82e8cf18910", "openfda": {"unii": ["3IG1E710ZN"], "rxcui": ["1655956", "1946772"], "spl_set_id": ["bd287e89-32f9-4396-95fa-4b562869f476"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL, MULTI-DOSE in 1 CARTON (61703-161-05)  / 2 mL in 1 VIAL, MULTI-DOSE (61703-161-02)", "package_ndc": "61703-161-05", "marketing_start_date": "20241104"}], "brand_name": "Methotrexate", "product_id": "61703-161_6bb8643f-6ab4-4e1c-bcf9-b82e8cf18910", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Folate Analog Metabolic Inhibitor [EPC]", "Folic Acid Metabolism Inhibitors [MoA]"], "product_ndc": "61703-161", "generic_name": "Methotrexate", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Methotrexate", "active_ingredients": [{"name": "METHOTREXATE SODIUM", "strength": "25 mg/mL"}], "application_number": "NDA011719", "marketing_category": "NDA", "marketing_start_date": "20241104", "listing_expiration_date": "20261231"}